Melexis
€69.50Change from previous close: +2.06%Absolute change: +€1.40
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €2.74B
- Enterprise value
- €3.01B
- P/E (trailing 12 months)
- 27.0
- Forward P/E
- 18.1
- PEG
- 1.70
- Price/book
- 6.44
- Price/sales
- 3.22
- EV/EBITDA
- 15.8
- EV/revenue
- 3.55
Profitability and growth
- Gross margin
- 39.4%
- Operating margin
- 17.8%
- Net margin
- 12.2%
- ROE
- 22.0%
- ROA
- 10.0%
- Revenue growth (year over year)
- 2.6%
- Earnings growth (year over year)
- -19.2%
Financial health
- Total cash
- €37.35M
- Total debt
- €301.03M
- Debt/equity
- 0.69
- Current ratio
- 5.87
- Quick ratio
- 2.90
Dividends
- Annual dividend per share
- €3.70
- Dividend yield
- 5.4%
- Payout ratio
- 144.0%
- Ex-dividend date
- October 13, 2026
Analysts and estimates
- Average price target
- €75.54
- Median price target
- €75.00
- High price target
- €97.00
- Low price target
- €56.00
- Analysts with a price target
- 13
- Consensus
- Hold
- Forward EPS
- €3.85
- EPS estimate, current year
- €3.03
Shares and trading
- Beta
- 1.53
- Average volume
- 44.14K
- Shares outstanding
- 39.38M
- Float
- 20.2M
- Institutional ownership
- 18.8%
- Insider ownership
- 50.0%